Mariusz Gryko

Waszyngtona 15a St
Bialystok, PD 15269, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

sCLEC-2 (Soluble C-Type Lectin-like Receptor 2) as a New Diagnostic Marker of Platelet Activation in Colorectal Cancer Patients-A Preliminary Study.

sCLEC-2 (Soluble C-Type Lectin-like Receptor 2) as a New Diagnostic Marker of Platelet Activation in Colorectal Cancer Patients-A Preliminary Study.

Journal: Diagnostics (Basel, Switzerland)

Published: February 20, 2026

The Clinical Relevance of Tumor Biomarkers in Prostate Cancer-A Review.

The Clinical Relevance of Tumor Biomarkers in Prostate Cancer-A Review.

Journal: Cancers

Published: October 28, 2025

Potential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer.

Potential Utility of A Proliferation-Inducing Ligand (APRIL) in Colorectal Cancer.

Journal: International journal of molecular sciences

Published: October 14, 2024

The caspase-8 and procaspase-3 expression in gastric cancer and non-cancer mucosa in relation to clinico-morphological factors and some apoptosis-associated proteins.

The caspase-8 and procaspase-3 expression in gastric cancer and non-cancer mucosa in relation to clinico-morphological factors and some apoptosis-associated proteins.

Journal: Advances in medical sciences

Published: September 09, 2022

Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer.

Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer.

Journal: Cancers

Published: September 21, 2021

The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.

The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.

Journal: Anticancer research

Published: January 20, 2021

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer.

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer.

Journal: International journal of molecular sciences

Published: August 11, 2020

CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.

CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.

Journal: International journal of molecular sciences

Published: February 24, 2020

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC).

Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC).

Journal: Oncotarget

Published: November 13, 2018

Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.

Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.

Journal: Polish archives of internal medicine

Published: July 31, 2018

The role of selected chemokines and their specific receptors in pancreatic cancer.

The role of selected chemokines and their specific receptors in pancreatic cancer.

Journal: The International journal of biological markers

Published: May 26, 2018

Blood serum levels of E-cadherin in patients with colorectal cancer.

Blood serum levels of E-cadherin in patients with colorectal cancer.

Journal: Przeglad gastroenterologiczny

Published: April 02, 2015

Showing 1-12 of 30

Last Updated: 09/26/2026